Mutant <i>PIK3CA</i> is a targetable driver alteration in histiocytic neoplasms
Benjamin H. Durham(Memorial Sloan Kettering Cancer Center), Roei David Mazor(Assuta Medical Center)
Cited by 10
Related Papers
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
|Nature Medicine|2019|226